Previous issues
-
Previous issues
Volume 27(4) Oct 2021
Print ISSN: 2287-2728
Online ISSN: 2287-285X
- Special Topic Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline
- Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim
- Clin Mol Hepatol. 2021;27(4):515-523.
- Reviews Three heads are better than two: Hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma
- Jer-Wei Wu, Jia-Horng Kao, Tai-Chung Tseng
- Clin Mol Hepatol. 2021;27(4):524-534.
- Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis
- Ho Soo Chun, A Reum Choe, Minjong Lee, Yuri Cho, Hwi Young Kim, Kwon Yoo, Tae Hun Kim
- Clin Mol Hepatol. 2021;27(4):535-552.
- Recent advances in nonalcoholic fatty liver disease metabolomics
- Hwi Young Kim
- Clin Mol Hepatol. 2021;27(4):553-559.
- Editorials Microwave thermosphere versus radiofrequency ablation for hepatocellular carcinoma: Are we approaching the time to end the debate?
- Man-Deuk Kim
- Clin Mol Hepatol. 2021;27(4):560-561.
- Can hepatocellular carcinoma recurrence be prevented after liver transplantation?
- Jong Man Kim
- Clin Mol Hepatol. 2021;27(4):562-563.
- Original Articles New next-generation microwave thermosphere ablation for small hepatocellular carcinoma
- Hideyuki Tamai, Jumpei Okamura
- Clin Mol Hepatol. 2021;27(4):564-574.
- Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis
- Chen-Hua Liu, Chi-Yi Chen, Wei-Wen Su, Chun-Jen Liu, Ching-Chu Lo, Ke-Jhang Huang, Jyh-Jou Chen, Kuo-Chih Tseng, Chi-Yang Chang, Cheng-Yuan Peng, Yu-Lueng Shih, Chia-Sheng Huang, Wei-Yu Kao, Sheng-Shun Yang, Ming-Chang Tsai, Jo-Hsuan Wu, Po-Yueh Chen, Pei-Yuan Su, Jow-Jyh Hwang, Yu-Jen Fang, Pei-Lun Lee, Chi-Wei Tseng, Fu-Jen Lee, Hsueh-Chou Lai, Tsai-Yuan Hsieh, Chun-Chao Chang, Chung-Hsin Chang, Yi-Jie Huang, Jia-Horng Kao
- Clin Mol Hepatol. 2021;27(4):575-588.
- Impact of everolimus on survival after liver transplantation for hepatocellular carcinoma
- Incheon Kang, Jae Geun Lee, Sung Hoon Choi, Hyun Jeong Kim, Dai Hoon Han, Gi Hong Choi, Myoung Soo Kim, Jin Sub Choi, Soon Il Kim, Dong Jin Joo
- Clin Mol Hepatol. 2021;27(4):589-602.
- Cost-effectiveness and long-term outcomes of liver transplantation using hepatitis B core antibody-positive grafts with hepatitis B immunoglobulin prophylaxis in Korea
- Kyeong Deok Kim, Ji Eun Lee, Jong Man Kim, Okjoo Lee, Na Young Hwang, Jinsoo Rhu, Gyu-Seong Choi, Kyunga Kim, Jae-Won Joh
- Clin Mol Hepatol. 2021;27(4):603-615.
- Letter to the Editor Impact of branched-chain amino acids and frailty on the management of lenvatinib-related fatigue in patients with hepatocellular carcinoma
- Shigeo Shimose, Shunji Koya, Takumi Kawaguchi, Keisuke Hirota, Sachiyo Yoshio, Takashi Niizeki, Hiroo Matsuse, Takuji Torimura
- Clin Mol Hepatol. 2021;27(4):616-619.
- Snapshot History and future of hepatitis B virus control in South Korea
- Do Young Kim
- Clin Mol Hepatol. 2021;27(4):620-622.